| Glioma is the most common highly malignant primary brain tumor. Nowdays themolecular pathways in the pathogenesis of glioma remain elusive. In order to clarify thesignal pathway, we showed that miR-107knockdown promoted cell growth in MO59Kby MTT analysis. FADD was increased in miR-107overexpressied glioma cell linesSHG44, U251and U87,and so was the activity of caspases8. Moreover, the activity ofcaspase8in miR-107-overexpressing SHG44cells was suppressed with FADDknockdown by rescue experiments, which suggest upregulation of miR-107suppressedglioma cell growth and induced apoptosis through the increase of FADD expression.To verify the downstream target molecules of miR-107, we usedImmunofluorescence,and the results indicated that SALL4expression wasdown-regulated in SHG44cells after miR-107overexpression,and SALL4expressionwas up-regulated in MO59K cells after miR-107knockdown.SALL43′-UTR-dependentluciferase activity was reduced by miR-107mimics in SHG44, U251and U87cells andwas increased in MO59K cells. These results show that the5′seed sequence of miR-107is important site to bind with SALL4.To investigate the function of oncogene SALL4, RNA interference experimentswere performed. SALL4downregulation triggered growth inhibition. Using Annexin Vand PI double staining method, qRT-PCR, western blot and caspase8, caspase3/7activity assay, we show that SALL4induced cell apoptosis and suppressed glioma cellgrowth through FADD upregulation. To clarify the role of SALL4in miR-107-inducedapoptosis, the rescue experiments were performed by SALL4overexpression. The resultshowed that the caspase-8activity in miR-107-overexpressing SHG44cells wassuppressed with SALL4upregulation, which suggests miR-107induces cell apoptosisby inhibiting the expression of SALL4.In summary, our results demonstrate upregulation of miR-107suppressed gliomacell growth through direct targeting of SALL4, leading to the activation ofFADD/caspase-8/caspase-3/7signaling pathway of cell apoptosis. These data suggestmiR-107is a potential therapeutic target against glioma. |